Tag: licensing
-
Start-Up Licenses Genetics Technology for HIV Diagnostics
19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed. Aldatu Biosciences is the creation of pathologist Iain MacLeod and geneticist David Raiser that…
-
Fast, Inexpensive Test for Water Bacteria Developed
18 May 2016. A team at York University in Toronto designed a water-testing kit connecting to a smartphone that makes testing for water-borne bacteria faster and less expensive. The Mobile Water Kit, from the lab of engineering professor Sushanta Mitra, is described in a recent issue of the journal Analyst (free registration required). Developers of the…
-
ReWalk, Wyss Institute Developing Soft Exoskeleton Robot
17 May 2016. A robotics company is licensing technology from a bioengineering lab at Harvard University to develop systems for people needing help with mobility, such as those with multiple sclerosis or suffering a stroke. Financial aspects of the deal between ReWalk Robotics Ltd. in Yokneam Ilit, Israel and the Wyss Institute for Biologically Inspired…
-
Biogen, UPenn Partner in $2B Gene Therapy Research Deal
16 May 2016. The biotechnology company Biogen is collaborating with University of Pennsylvania’s medical school on research into gene therapies and editing, with payments to the university totaling as much as $2 billion. The partnership will fund research in the labs of University of Pennsylvania medical professors James Wilson and Jean Bennett, who study gene…
-
Collaborations Study Microbiome in Cancer, Metabolic Disease
12 May 2016. The biopharmaceutical company Seres Therapeutics is sponsoring research into the role of gut microbes in cancer and metabolic disorders, at Memorial Sloan Kettering Cancer Center and University of Pennsylvania. Financial ]aspects of the agreements between Seres, in Cambridge, Massachusetts, and Memorial Sloan Kettering and Penn were not disclosed. Seres Therapeutics discovers and…
-
Genome-Editing Company Raises $108 Million in IPO
6 May 2016. Intellia Therapeutics, a developer of therapies based on genome editing, issued its initial public stock offering, raising $108 million. The Cambridge, Massachusetts enterprise, less than 2 years old, issued 6 million shares priced at $18.00. At the 4:00 pm ET closing bell today, company shares trading on the NASDAQ exchange as NTLA…
-
University Lab Spins-Off Fertility Testing Company
29 April 2016. A new company is taking shape that aims to make it easier for women to get pregnant, based on research at a biochemistry lab at University of Wisconsin. BluDiagnostics, in Madison, founded by postdoctoral research Katie Brenner in the lab of biochemistry professor Douglas Weibel, a co-founder of the company, already raised…
-
Nanoparticles Designed for Asthma, Allergy Treatments
19 April 2016. A technique for masking allergy or asthma treatments in biodegradable nanoparticles is shown in lab mice to quickly build a tolerance in the immune system for offending allergens. A medical and engineering team at Northwestern University in Chicago published its findings yesterday, 18 April, in Proceedings of the National Academy of Sciences…
-
Start-Up Licensing Biologic Delivery Nanoparticles
8 April 2016. A start-up enterprise is licensing research from a university pharmacy lab that harnesses nanoscale particles to boost the performance of biologic therapies. Financial details of the agreement between Zoetic Pharmaceuticals in Amherst, New York and University at Buffalo were not disclosed. Biologic therapies are synthetic proteins derived from living systems, such as…
-
Stem Cell Biotech Licensing Blood Vessel Repair Technology
6 April 2016. Cellular Dynamics International, a developer of regenerative treatments from stem cells, is licensing university research that repairs blood vessels in people with peripheral artery disease. Financial aspects of the deal between Indiana University and Cellular Dynamics, a subsidiary of FujiFilm in Madison, Wisconsin, were not disclosed. Cellular Dynamics designs and generates induced…